Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Standards & Regulation

Manufacture Clinical Trials

Pregnant Patients Deserve Better

| Anne Drapkin Lyerly

The lack of evidence available from pharma companies to guide care of pregnant women is ethically unacceptable.

Manufacture Clinical Trials

Time for Pharma to Deliver?

| Roisin McGuigan

Is pharma putting women and children last?

Business & Regulation Standards & Regulation

The True Cost of Falsified Medicine

| Roisin McGuigan

A recent review and meta-analysis highlights the huge impact of fake and substandard drugs.

Manufacture Clinical Trials

Right for Patients?

| Ellen Sigal

“Right to Try” legislation may have compassion at its heart, but it does not do enough to ensure patient protection.

Manufacture Standards & Regulation

The Costs of the Counterfeit Battle

| Maarten Van Baelen

Fighting counterfeit medicines is a noble goal, but the financial burden of safety features may affect access to medicines in unintended ways.

Business & Regulation Small Molecules

The Marijuana Medicine Makers

| Kevin Hennessy

Interest in cannabinoid drug development is growing. The potential market – and the opportunity to treat unmet patient needs – is enormous.

Manufacture Standards & Regulation

Getting to Grips With the New Generation

| Herb Lutz and Brian Hubbard

How will biopharmaceutical process development be affected by next-generation technologies?

Business & Regulation Packaging

Designing Packaging for the Elderly

| Stephen Wilkins

Why are we still making life difficult for a growing patient population when solutions exist?

Business & Regulation Business Practice

MAICing a Decision

| James Strachan

Do methods that compare newly approved drugs with those already on the market help cut healthcare costs?

Business & Regulation Business Practice

Brexit: Preparing Is Caring

| James Strachan

Most, but not all, UK pharma companies are on track to keep their medicines on the European market by March, 2019.

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register